Drug containment considerations for bringing mRNA drugs successfully to the market
Download the whitepaper now to explore the role of primary packaging in the success of mRNA-based therapies!
Leading mRNA pharmaceutical companies are expanding their drug pipelines for therapeutic areas such as prophylactic vaccines against infectious diseases, rare diseases, and oncology. These mRNA-based drugs require primary packaging containers for storage, transport, and injection. Moreover, several factors will influence the choice of drug containment solutions to ensure that the primary container contributes to the successful launch of these drugs.
Read the whitepaper now to discover the key drug containment considerations for bringing mRNA drugs successfully to the market!
The article was initially published in the Medicine Maker in April 2022.
Leading mRNA pharmaceutical companies are expanding their drug pipelines for therapeutic areas such as prophylactic vaccines against infectious diseases, rare diseases, and oncology. These mRNA-based drugs require primary packaging containers for storage, transport, and injection. Moreover, several factors will influence the choice of drug containment solutions to ensure that the primary container contributes to the successful launch of these drugs.
Read the whitepaper now to discover the key drug containment considerations for bringing mRNA drugs successfully to the market!
The article was initially published in the Medicine Maker in April 2022.
